Novartis, Ratio sign radiopharmaceutical pact to the tune of $745M biobucks
Novo’s Wegovy launched in China at a fraction of US price
COVID-era telehealth prescribing extended again
Gilead’s Livdelzi shows promise in PBC clinical trial
*please scroll down for all the latest news*